Managing Hope When Treatment Might Work Brilliantly — or Not at All

Hope for something specific and near — this cycle, this scan, one good month — rather than for a single all-or-nothing outcome. Realistic hope names what you are hoping for, accepts that immunotherapy helps only a proportion of patients, and keeps a plan ready for the outcome you are not hoping for.

The word most families reach for is “positive”, as in stay positive. It is well meant, and it quietly makes things harder. It turns hope into a duty, so any honest sentence — I am frightened, I do not think this is working — starts to feel like a betrayal of the person being treated. Hope that can survive being spoken about honestly lasts longer than hope that has to be protected from the truth.

Immunotherapy stretches this further than most treatments, because the answer takes months to arrive and arrives in pieces. That is the part nobody prepares you for: not the treatment itself, but the length of the not-knowing.

Nothing on this page is a diagnosis of a mental-health condition, and no webpage can tell you how you ought to feel. If distress is persistent, a qualified psycho-oncologist is the right person to speak to — see when to ask for psycho-oncology support below.

Because the outcomes are unusually split. With immunotherapy, some patients have a response that lasts a long time, while many others get no benefit at all — and in the first weeks there is often no reliable way to tell which group you are in. The uncertainty runs for months, not days.

Chemotherapy tends to produce a more predictable arc. Families learn roughly what each cycle feels like, and results arrive on a schedule. Immunotherapy does not behave that way. Side effects can appear weeks or even months after a dose, and the effect on the tumour can take longer to show on imaging. Your oncologist may repeat a scan before drawing a conclusion, because immunotherapy response is harder to read on a scan than chemotherapy response. Response-assessment scans are coordinated at partner imaging centres, and the report is reviewed by your treating team before anything is decided.

The internet makes this harder still. The stories that travel are the extraordinary ones, because those are the stories worth telling — which leaves families quietly measuring an ordinary, uncertain treatment course against the most remarkable outcomes online. Ask your oncologist for the response range that bodies such as NCCN, ASCO or ESMO cite for your specific cancer type and biomarker status, and treat any number you read elsewhere as belonging to someone else’s case, not yours.

Usually by giving family members different jobs instead of demanding one shared mood. One person tracks the medical facts, one protects the patient’s day-to-day comfort, one handles money and paperwork. Disagreement about how hopeful to be is normal, and it does not have to be resolved for a family to work well together.

The adult child who researches everything usually ends up as the family’s realist, and it is a lonely job. You read the studies, you understand what the scan report means, and then you sit in a room where everyone wants you to say something reassuring. Say the true thing to at least one person — a sibling, a friend, a counsellor — so that you are not the only one holding it.

Patients and caregivers often want different amounts of information, and that is allowed. Some patients want every detail; others want only the next step. Ask directly — how much do you want to know before this scan? — rather than deciding for them. Agreeing who hears the result first, and how it gets shared, prevents the worst version of scan day.

Relatives and neighbours will offer certainty that your oncologist cannot: a treatment that worked for someone they know, a reason it will definitely work, or advice to try something else instead. A short, repeatable line helps — the oncologist reviews it at every scan, and we are following that plan. You do not owe anyone the full picture. If that pressure is specifically about switching to an alternative system of medicine, handling advice to try alternative treatment instead covers how to answer it without a family argument.

When treatment is palliative in intent, hope does not disappear — it changes address. It moves to good days, comfort, being at home, a family event you want to reach. That is not a lesser hope, and naming it out loud usually relieves more pressure than continuing to talk in terms of one single outcome.

Care changes direction; it does not stop. If scans show the cancer is not responding, your oncologist reviews the other systemic treatment options appropriate for your cancer type, clinical trials you may be eligible for, and best supportive or palliative care. Stopping one treatment is a change of plan, not the end of treatment.

It is usually a scan that tells you, sometimes with symptoms alongside it. Because immunotherapy response is difficult to interpret on imaging, your oncologist may repeat the scan or take it to the tumour board before concluding that the treatment is not working. Ask what the next step would be before the scan rather than after — it changes how that day feels.

What follows is grief, and it usually arrives with a financial edge: the sense that the family spent a great deal on something that did not work. It is worth saying plainly that a decision made from good information is a good decision, whatever result follows it. Nobody could know in advance which group you would be in — that uncertainty is exactly why the decision was difficult. If money is now the hardest conversation in the house, telling family and community about an expensive treatment deals with it directly.

If treatment has worked and been stopped, the difficulty inverts: the fear that it comes back sits underneath every good month. Fear of recurrence after stopping immunotherapy is about that version of the problem, which families rarely expect and almost never plan for.

Five things, and none of them require certainty. Ask your oncologist for both plans in writing. Agree one question before each scan. Fix a date to review cost rather than doing it in a crisis. Appoint one person to handle information. Protect one hour that is not about cancer.

When distress stops lifting on its own — sleep gone for weeks, no interest in anything you used to enjoy, panic before every scan, or thoughts of self-harm. That is the point to see a qualified psycho-oncologist. It is a clinical service like any other, not a personal failure or a sign that you have stopped coping.

A psycho-oncologist is a mental-health professional who works specifically with cancer patients and their families. The work is practical: scan anxiety, sleep, communication inside the family, and the fear that fills the gap between cycles. Ask your CION care team to connect you with a psycho-oncologist, and ask for yourself as well as for the patient — caregivers are eligible for the same support and rarely request it.

Nothing on this page diagnoses depression, anxiety or any other condition, and it is not a substitute for assessment by a qualified professional. Only a trained clinician can make that call.

• If treatment has worked and been stopped, and every good month now carries a question mark, read Fear of Recurrence After Stopping Immunotherapy.
• If relatives keep pressing you to try something else instead, Handling Advice to Try Alternative Treatment Instead gives you a way to answer without a family argument.
• If the money is the part you cannot talk about, Telling Family and Community About an Expensive Treatment is written for exactly that conversation.
• For how immunotherapy is delivered, monitored and reviewed at our centres, see Immunotherapy at CION Cancer Clinics.

Carrying this for someone in your family? Book a free consultation and bring your questions — including the ones you have not asked in front of the patient.